BKU plans sale of 3,000 common shares

An affiliate of BKU has filed to sell up to 3,000 shares of the issuer’s common stock through Raymond James & Associates.

Rhea-AI Filing Summary

An affiliate of BKU has filed to sell up to 3,000 shares of the issuer’s common stock through Raymond James & Associates. The planned sale, listed on the NYSE for $143,700.00 in aggregate market value, is against a base of 72,681,714 shares outstanding.

The 3,000 shares were previously acquired from the issuer for cash in three purchases on 05/20/2019, 05/15/2021, and 05/18/2022.

Key Figures

Shares to be sold: 3,000 shares Aggregate market value: $143,700.00 Shares outstanding: 72,681,714 shares +3 more

6 metrics

Shares to be sold 3,000 shares Common stock proposed for sale under Form 144

Aggregate market value $143,700.00 Total market value of 3,000 shares to be sold

Shares outstanding 72,681,714 shares Issuer’s common shares outstanding as referenced in the filing

Purchase on 05/18/2022 2,160 shares Common shares purchased from issuer for cash

Purchase on 05/15/2021 839 shares Common shares purchased from issuer for cash

Purchase on 05/20/2019 1 share Common share purchased from issuer for cash

Key Terms

Securities Information, Securities To Be Sold, aggregate market value

3 terms

Securities Information regulatory

"144: Securities Information Common | Raymond James & Associates"

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 05/18/2022 | Purchase"

aggregate market value financial

"Common | Raymond James & Associates 880 Carillon St. Petersburg FL 33716 | 3000 | 143700.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for BKU disclose?

The Form 144 discloses a proposed sale of 3,000 shares of BKU common stock with an aggregate market value of $143,700.00, to be sold through Raymond James & Associates on the NYSE, subject to Rule 144 conditions.

How many BKU shares are planned to be sold and at what value?

The filer plans to sell 3,000 shares of BKU common stock with an aggregate market value of $143,700.00. This indicates an implied per-share value of about $47.90, based on the reported total market value and share count.

What is BKU’s share count context for this Form 144 sale?

The issuer has 72,681,714 shares outstanding, providing context for the planned sale of 3,000 shares. The filing presents this outstanding share figure as a baseline for assessing the relative size of the proposed disposition.

When were the BKU shares being sold originally acquired?

The 3,000 BKU shares were bought directly from the issuer for cash in three lots: 1 share on 05/20/2019, 839 shares on 05/15/2021, and 2,160 shares on 05/18/2022. All acquisitions were reported as purchases from the issuer.

Is there any BKU stock sold by this filer in the past 3 months?

The Form 144 section for Securities Sold During The Past 3 Months contains no specific BKU transactions. The filing instead details only the proposed sale of 3,000 shares and the historical purchase dates and amounts from earlier years.

Which broker is handling the planned BKU share sale?

The planned sale of 3,000 BKU shares is listed through Raymond James & Associates, located at 880 Carillon in St. Petersburg, FL 33716. The filing associates this broker with the NYSE transaction for the reported aggregate value of $143,700.00.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 01:55 PM Accepted by SEC EDGAR 08/13/2026 - 01:54 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001221213
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BankUnited, Inc.
SEC File Number	001-35039
Address of Issuer	14817 OAK LANE MIAMI LAKES FLORIDA 33016
Phone	(305) 569-2000
Name of Person for Whose Account the Securities are To Be Sold	PAULS DOUGLAS J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon St. Petersburg FL 33716	3000	143700.00	72681714	08/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/18/2022	Purchase	Issuer			2160	05/18/2022	Cash
Common	05/15/2021	Purchase	Issuer			839	05/15/2021	Cash
Common	05/20/2019	Purchase	Issuer			1	05/20/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Douglas J Pauls
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)